logo
episode-header-image
Mar 2025
30m 7s

The State of Weight-Loss Drugs

The Motley Fool
About this episode
$150 billion. That’s how much some experts estimate weight-loss drugs could bring in in sales within the next five years. Motley Fool analyst Karl Thiel joins Ricky Mulvey to check in on the GLP-1 landscape. They also discuss: - How weight-loss drugs actually work, and how big-name prescriptions differ from each other. - What investors need to know about O ... Show More
Up next
Today
Picking the Winners of the Honeywell Breakup
The Honeywell International of 10 years ago is now six different publicly traded companies. This week, Honeywell International split with Honeywell Aerospace to complete the pre-planned separation. Tyler, Matt, and Lou look break down the prospects for the disparate parts as stan ... Show More
27m 18s
Yesterday
Rocket Lab Shakes Up Satellite Communications
Jon, Matt, and Rachel dissect the latest breakup news from Comcast as the media giant intends to spin off assets under its NBCUniversal entity. This could unlock value but could shake up the streaming landscape. The team then moves on to Rocket Lab’s $8 billion acquisition of Iri ... Show More
21m 27s
Jun 28
The AI Headlines You Should Be Most Suspicious Of
The companies dominating AI headlines right now may not be the ones actually winning. In fact, according to Julie Averill, the loudest signals are often the ones most worth questioning. As former global CIO of Lululemon — where she helped oversee one of retail's most successful t ... Show More
28m 48s
Recommended Episodes
Sep 2024
#766: The Random Show — Lessons from Tim’s Sabbatical, Alzheimer's Breakthroughs, Kevin Tries a Medium, Fitness Tools and Protocols, Book Recommendations, and More
This time, we have a very special episode I recorded with my close friend Kevin Rose in person at his house. We trade our latest discoveries, and I think it’s one of our best. Tons of actionable takeaways and laughing fits. We cover dozens of topics: new projects, what I’ve done ... Show More
2h 4m
Oct 2024
Modern Medicine and its Blind Spots — with Dr. Marty Makary
Dr. Marty Makary, a renowned surgeon and professor at Johns Hopkins, public health expert, and a two-time New York Times bestselling author, joins Scott to discuss his latest book, Blind Spots: When Medicine Gets It Wrong, and What It Means for Our Health. They go over topics inc ... Show More
51m 8s
Apr 2025
ICYMI: Eli Lilly's New Weight Loss Pill
Shares in Eli Lilly surged on Friday  after its experimental pill helped patients shed weight and control blood sugar about as well as Ozempic, an advance that could turbocharge what’s already one of the fastest growing markets in medicine. Shares of the drug’s originator Chugai ... Show More
7m 16s
Sep 2025
#828: David Senra — How Extreme Winners Think and Win: Lessons from 400+ of History’s Greatest Founders and Investors (Including Buffett, Munger, Rockefeller, Jobs, Ovitz, Zell, and Names You Don’t Know But Should)
David Senra is the host of the Founders podcast. For the past nine years, David has intensely studied the life and work of hundreds of history’s greatest entrepreneurs. His new podcast, David Senra, showcases conversations with the best-of-the-best living founders and extreme win ... Show More
2h 55m
Jul 2025
My Billion Dollar Shark Tank Investment: Daymond John
Join Codie Sanchez as she dives deep with Daymond John, the founder of FUBU and a star on Shark Tank, in this insightful episode of the Big Deal podcast. They discuss his journey from starting FUBU in his mom's house to building it into a $6 billion brand, his investment strategi ... Show More
1h 7m
Nov 2025
The end of dieting
The Trump administration is making GLP-1s more affordable. This class of drugs seems to have forever changed the game on diet and exercise for Americans. This episode was produced by Miles Bryan, edited by Jolie Myers, fact-checked by Laura Bullard, engineered by Patrick Boyd and ... Show More
25m 50s
Oct 2025
Forensic Account: The Bubble No One is Talking About | Anthony Scilipoti
Anthony Scilipoti is one of the sharpest minds in investing. He's the President and CEO of Veritas Group of Companies. He called the collapses of both Valeant Pharmaceuticals and Nortel before they happened, and now he has some thoughts on AI. We talk about asking better question ... Show More
1h 34m
Aug 2025
The Biggest Risk Investors Face Today
tail spinning
39m 16s
Jul 2025
Jimmy Pattison: Building a $16B Empire Without Connections, Capital, or Credentials [Outliers]
Jimmy Pattison still runs his $16 billion empire personally at 96 years old. He’s built The Pattison Group over the last 63 years without outside capital or a college degree. He owns 100% of car dealerships, grocery stores, billboards, radio stations and even Ripley’s Believe It ... Show More
1h 11m